Postpartum Management of Hypertension in Pregnancy With Hydrochlorothiazide
A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 453 participants.
Also called NCT03298802
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 453 participants
- Sponsor
- The University of Texas Medical Branch, Galveston
- Registry
-
NCT03298802
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Terminated
Technical summary
Registry record NCT03298802. Randomized; triple masking; primary purpose prevention. Start 2017-11-21 (actual); primary completion 2025-04-22 (actual). Results posted on 2026-06-24.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Postpartum Management of Hypertension in Pregnancy With Hydrochlorothiazide
- Condition
- Pre-Eclampsia
- Condition
- Gestational Hypertension
- Condition
- Superimposed Pre-Eclampsia
- Condition
- Hypertension, Pregnancy-Induced
- Condition
- Postpartum Pregnancy-Induced Hypertension
- Condition
- Postpartum Preeclampsia
- Intervention (Drug)
- Hydrochlorothiazide 50mg Tablet
- Intervention (Drug)
- Placebo Tablet
- Lead sponsor
- The University of Texas Medical Branch, Galveston
Record details
- Record id
cardio:ct-nct03298802- Content hash
6fa1637bb2f11c2993f88625f3e5be6f6ff3a53021497b18bf0b7ae6ae3f9348